This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
All You Need to Know About Idex (IEX) Rating Upgrade to Buy
by Zacks Equity Research
Idex (IEX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Down 12.2% in 4 Weeks, Here's Why Idex (IEX) Looks Ripe for a Turnaround
by Zacks Equity Research
Idex (IEX) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
IDEX (IEX) Lags on Q4 Earnings, Projects Y/Y Growth for 2022
by Zacks Equity Research
IDEX's (IEX) Q4 earnings reflect the impacts of strength in segmental businesses and synergies from acquired assets. It predicts year-over-year growth in earnings per share for 2022.
Idex (IEX) Misses Q4 Earnings Estimates
by Zacks Equity Research
Idex (IEX) delivered earnings and revenue surprises of -2.52% and 1.27%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Should You Buy IDEX (IEX) Ahead of Earnings?
by Zacks Equity Research
IDEX (IEX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Idex (IEX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Idex (IEX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
IDEX (IEX) Gains From End-Market Strength Amid Cost Woes
by Zacks Equity Research
IDEX (IEX) benefits from solid product offerings, strengthening end markets, buyout synergies, and shareholder-friendly policies. Supply-chain, cost inflation and logistics issues are concerning.
Idex (IEX) Up 6.2% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Idex (IEX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
IDEX (IEX) Enters Into Deal to Acquire Nexsight for $120M
by Zacks Equity Research
IDEX's (IEX) acquisition of Nexsight will enable it to strengthen its iPEK and ADS business units in the wastewater inspection market.
Ingersoll (IR) on Buyout Spree, To Acquire Tuthill Pump Group
by Zacks Equity Research
Ingersoll's (IR) buyout of Tuthill Pump Group will help strengthen existing pumping solution offerings in the Precision and Science Technologies segment.
Amcor (AMCR) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Amcor's (AMCR) first-quarter 2022 results are likely to reflect strong demand in end markets and synergies from the Bemis acquisition, somewhat offset by higher input costs.
IDEX (IEX) Beats Q3 Earnings Estimates, Revises 2021 View
by Zacks Equity Research
IDEX's (IEX) Q3 earnings reflect the impacts of healthy segmental sales and margin improvement despite high costs due to prevalent headwinds. It revises earnings projection for 2021.
Idex (IEX) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
Idex (IEX) delivered earnings and revenue surprises of 1.87% and 2.14%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Industrial Stocks Q3 Earnings to Watch on Oct 26: IEX and More
by Payal Jalan
The Q3 results of Industrial stocks IEX, PNR, HUBB and XRX on Oct 26 are likely to reflect the impacts of strengthening end markets. Supply-chain and inflationary woes are likely to have ailed.
Idex (IEX) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Idex (IEX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
End Markets to Aid Altra Industrial (AIMC), Supply-Chain Hurts
by Zacks Equity Research
Altra Industrial (AIMC) is set to gain from solid product offerings, healthy end-market demands and debt-reduction actions. Inflation in raw material prices and supply-chain issues are concerning.
IDEX (IEX) Gains From Segmental Strength Amid Supply-Chain Woes
by Zacks Equity Research
IDEX (IEX) seems to benefit from a healthy product demand in end markets, including industrial, water and life sciences. Supply-chain, inflation and logistics woes are likely to affect the company.
Solid Demand Aids Illinois Tool (ITW), Supply Chain & Costs Hurt
by Zacks Equity Research
Illinois Tool (ITW) is benefiting from healthy end-market demand. Supply-chain restrictions and inflation in prices of raw materials are concerning, and likely to impact margins.
SXI vs. IEX: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
SXI vs. IEX: Which Stock Is the Better Value Option?
The Zacks Analyst Blog Highlights: Deere, DXP Enterprises, Columbus McKinnon and IDEX Corp
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Deere, DXP Enterprises, Columbus McKinnon and IDEX Corp
Xylem (XYL) and Dragos to Provide Cybersecurity Solutions
by Zacks Equity Research
Xylem's (XYL) partnership with Dragos will enable it to offer co-branded incident response and incident prevention services to customers in the water utility sector.
4 Top-Ranked Industrial Stocks to Buy for a Q4 Rally
by Tirthankar Chakraborty
With the manufacturing side of the US economy still driven by strong demand for goods, it's judicious to invest in stocks such as Deere (DE) & IDEX (IEX) this quarter.
Cintas (CTAS) to Report Q1 Earnings: What's in the Offing?
by Zacks Equity Research
Cintas (CTAS) Q1 earnings to reflect healthy business in the hygiene and healthcare markets, gains from buyouts, and solid product offerings. High costs and taxes are likely to have been concerning.
Here's Why it is Worth Investing in IDEX (IEX) Stock Now
by Zacks Equity Research
IDEX (IEX) is poised to benefit from strength in end markets, acquired assets, and shareholder-friendly policies.
Zacks Industry Outlook Highlights: Dover, Ingersoll Rand, IDEX and Nordson
by Zacks Equity Research
Zacks Industry Outlook Highlights: Dover, Ingersoll Rand, IDEX and Nordson